Table 2.
Percentage of control and treated MCF-7 cells in cell cycle phases
| Percentage of cells in cell cycle phases | |||||
|---|---|---|---|---|---|
| Sub-G1 | G1 | S | G2/M | ||
| 24 h | Control | 1.39 ± 1.37 | 34.68 ± 3.77 | 22.13 ± 0.46 | 26.36 ± 2.38 |
| NDL | 0.62 ± 0.04 | 32.74 ± 0.73 | 23.76 ± 2.06 | 24.11 ± 2.11 | |
| 36 h | Control | 0.81 ± 0.63 | 47.26 ± 1.73 | 22.06 ± 2.11 | 19.56 ± 1.41 |
| NDL | 3.18 ± 0.78* | 49.08 ± 3.42 | 21.26 ± 0.22 | 16.93 ± 1.55 | |
| 48 h | Control | 0.64 ± 0.47 | 50.00 ± 1.49 | 21.04 ± 2.47 | 16.77 ± 1.25 |
| NDL | 5.04 ± 0.90** | 54.87 ± 2.26 | 15.97 ± 3.79 | 15.23 ± 6.21 | |
| 60 h | Control | 3.90 ± 2.88 | 59.27 ± 1.67 | 17.08 ± 0.68 | 14.67 ± 0.31 |
| NDL | 35.38 ± 2.26*** | 40.47 ± 1.33*** | 13.05 ± 1.61** | 8.50 ± 0.34*** | |
Each value represents the mean ± SD (n = 3). The statistical differences between the treatment and control were analyzed by the two-tailed paired Student’s t-tests (* < 0.05, **p < 0.01; ***p < 0.001)